D J Klos

651 total citations
19 papers, 562 citations indexed

About

D J Klos is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, D J Klos has authored 19 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in D J Klos's work include TGF-β signaling in diseases (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Cell Adhesion Molecules Research (3 papers). D J Klos is often cited by papers focused on TGF-β signaling in diseases (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Cell Adhesion Molecules Research (3 papers). D J Klos collaborates with scholars based in United States and Australia. D J Klos's co-authors include J. A. Fernandez‐Pol, Paul D. Hamilton, Venugopal D. Talkad, Gregory A. Grant, Robert M. Donati and Daniel J. Santa Cruz and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

D J Klos

19 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D J Klos United States 15 368 163 63 59 52 19 562
C Radzikowski Poland 13 294 0.8× 144 0.9× 69 1.1× 53 0.9× 32 0.6× 72 656
W. A. Dengler Germany 8 254 0.7× 173 1.1× 85 1.3× 31 0.5× 48 0.9× 10 532
Mark D. Schuchard United States 10 457 1.2× 59 0.4× 56 0.9× 106 1.8× 38 0.7× 15 780
Bradford O. Fanger United States 11 315 0.9× 93 0.6× 30 0.5× 48 0.8× 75 1.4× 18 462
S. Estrade France 13 324 0.9× 125 0.8× 57 0.9× 124 2.1× 12 0.2× 30 507
Jean Bowen United States 3 348 0.9× 69 0.4× 125 2.0× 39 0.7× 53 1.0× 4 625
James F. Whitfield Canada 9 445 1.2× 174 1.1× 43 0.7× 40 0.7× 13 0.3× 20 574
Natalya V. Narizhneva Russia 10 392 1.1× 118 0.7× 74 1.2× 31 0.5× 64 1.2× 11 660
John D. Benson United States 16 520 1.4× 168 1.0× 100 1.6× 82 1.4× 21 0.4× 22 946
J E Zuckerman United States 12 473 1.3× 141 0.9× 48 0.8× 34 0.6× 32 0.6× 12 784

Countries citing papers authored by D J Klos

Since Specialization
Citations

This map shows the geographic impact of D J Klos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D J Klos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D J Klos more than expected).

Fields of papers citing papers by D J Klos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D J Klos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D J Klos. The network helps show where D J Klos may publish in the future.

Co-authorship network of co-authors of D J Klos

This figure shows the co-authorship network connecting the top 25 collaborators of D J Klos. A scholar is included among the top collaborators of D J Klos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D J Klos. D J Klos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Klos, D J, et al.. (2002). Antiviral, cytotoxic and apoptotic activities of picolinic acid on human immunodeficiency virus-1 and human herpes simplex virus-2 infected cells.. PubMed. 21(6A). 3773–6. 48 indexed citations
2.
Fernandez‐Pol, J. A., et al.. (2001). Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents: implications for prevention and therapy of viral diseases and cancer.. PubMed. 21(2A). 931–57. 36 indexed citations
3.
Cruz, Daniel J. Santa, et al.. (1997). Differential expression of metallopanstimulin/S27 ribosomal protein in melanocytic lesions of the skin. Journal of Cutaneous Pathology. 24(9). 533–542. 22 indexed citations
4.
Klos, D J, et al.. (1994). Expression of metallopanstimulin in condylomata acuminata of the female anogenital region induced by papilloma virus.. PubMed. 14(3A). 773–86. 5 indexed citations
5.
Fernandez‐Pol, J. A., et al.. (1994). Metallopanstimulin gene product produced in a baculovirus expression system is a nuclear phosphoprotein that binds to DNA.. PubMed. 5(8). 811–25. 25 indexed citations
6.
Fernandez‐Pol, J. A., et al.. (1993). A growth factor-inducible gene encodes a novel nuclear protein with zinc finger structure.. Journal of Biological Chemistry. 268(28). 21198–21204. 45 indexed citations
7.
Fernandez‐Pol, J. A., D J Klos, & Paul D. Hamilton. (1993). Cytotoxic activity of fusaric acid on human adenocarcinoma cells in tissue culture.. PubMed. 13(1). 57–64. 32 indexed citations
8.
Klos, D J, et al.. (1992). Expression of transforming growth factor alpha mRNA in benign and malignant tissues derived from gynecologic patients with various proliferative conditions.. PubMed. 12(4). 1115–20. 16 indexed citations
10.
Fernandez‐Pol, J. A., et al.. (1989). Transcriptional Regulation of Proto-oncogene Expression by Epidermal Growth Factor, Transforming Growth Factor β1, and Triiodothyronine in MDA-468 Cells. Journal of Biological Chemistry. 264(7). 4151–4156. 30 indexed citations
11.
Fernandez‐Pol, J. A., Venugopal D. Talkad, D J Klos, & Paul D. Hamilton. (1987). Suppression of the EGF-dependent induction of c-myc proto-oncogene expression by transforming growth factor β in a human breast carcinoma cell line. Biochemical and Biophysical Research Communications. 144(3). 1197–1205. 59 indexed citations
12.
Fernandez‐Pol, J. A., et al.. (1987). Modulation of epidermal growth factor receptor gene expression by transforming growth factor-beta in a human breast carcinoma cell line.. PubMed. 47(16). 4260–5. 38 indexed citations
13.
Fernandez‐Pol, J. A., D J Klos, & Gregory A. Grant. (1986). Purification and biological properties of type beta transforming growth factor from mouse transformed cells.. PubMed. 46(10). 5153–61. 41 indexed citations
14.
Fernandez‐Pol, J. A., Paul D. Hamilton, & D J Klos. (1982). Correlation between the loss of the transformed phenotype and an increase in superoxide dismutase activity in a revertant subclone of sarcoma virus-infected mammalian cells.. PubMed. 42(2). 609–17. 60 indexed citations
15.
Fernandez‐Pol, J. A., D J Klos, & Paul D. Hamilton. (1981). Viral transformation involves loss of epidermal growth factor‐stimulated phosphorylation of two specific membrane polypeptides in normal rat kidney cells. FEBS Letters. 124(2). 219–224. 6 indexed citations
16.
Fernandez‐Pol, J. A. & D J Klos. (1980). Isolation and characterization of normal rat kidney cell membrane proteins with affinity for transferrin. Biochemistry. 19(17). 3904–3912. 43 indexed citations
17.
Klos, D J, et al.. (1980). Mechanism of hepatic extraction of gelatinized 99mTechnetium sulfur colloid. European Journal of Nuclear Medicine and Molecular Imaging. 5(3). 241–245. 17 indexed citations
18.
Fernandez‐Pol, J. A., D J Klos, & Robert M. Donati. (1978). Iron transport in NRK cells synchronized in G by picolinic acid. Cell Biology International Reports. 2(5). 433–439. 9 indexed citations
19.
Klos, D J, et al.. (1978). Osmium staining of technetium sulfur colloid: A techniqu for electron microscopy. International Journal of Nuclear Medicine and Biology. 5(1). 56–58. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026